ChuCRRodeoSBhutaniN, et al. Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS/NIH U-13 Conference. J Am Acad Orthop Surg. 2019;27(2):e50-e63.
2.
ColeBJKarasVHusseyKPilzKFortierLA. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2017;45(2):339-346.
3.
MalangaGJayaramP. Need for proper classification of PRP: letter to the editor. Am J Sports Med. 2017;45(6):NP23-NP24.
4.
MautnerKMalangaGASmithJ, et al. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R. 2015;7(4):S53-S59.
5.
MazzuccoLBalboVCattanaEGuaschinoRBorziniP. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang. 2009;97(2):110-118.
6.
SchwitzguebelAJKoloFCTirefortJ, et al. Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus tears: a double-blinded, randomized controlled trial. Am J Sports Med. 2019;47(8):1885-1892.
